Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.78 billion.

Boston Scientific sees FY2015 EPS of $0.88-$0.92, versus the consensus of $0.91. Boston Scientific sees FY2015 revenue of $7.225-7.375 billion, versus prior guidance of $7.30-7.5 billion and the consensus of $7.43 billion.

For earnings history and earnings-related data on Boston Scientific (BSX) click here.